Skip to main content
. 2004 Dec 15;10(24):3650–3653. doi: 10.3748/wjg.v10.i24.3650

Figure 1.

Figure 1

Concentration of sFas and sFasL in HBV infected patients and chronic hepatitis C patients. A: Concentration of sFas in HBV infected patients B: Concentration of sFasL in chronic hepatitis C patients.